Evidence map›Paper›PMID 35081582›Full record

ArticleJournal of hypertension2022

Hypertension and contraceptive use among women of child-bearing age in the United States from 2001 to 2018.

Lara C Kovell, Claire V Meyerovitz, Ekaterina Skaritanov, Didem Ayturk, Sharina D Person, Tara Kumaraswami, Stephen P Juraschek, Tiffany A Moore Simas

Open access · greenAbstract read
In one paragraph

Article in Journal of hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lara C KovellDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School.
Claire V MeyerovitzUniversity of Massachusetts Chan Medical School.
Ekaterina SkaritanovUniversity of Massachusetts Chan Medical School.
Didem AyturkDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School.
Sharina D PersonDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School.
Tara KumaraswamiDepartment of Obstetrics and Gynecology, University of Massachusetts Chan Medical School, Worcester.
Stephen P JuraschekDivision of General Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston.
Tiffany A Moore SimasDepartment of Obstetrics and Gynecology, University of Massachusetts Chan Medical School, Worcester.
University of Massachusetts Chan Medical School · USBeth Israel Deaconess Medical Center · US

Funding

Vitamin D, Subclinical Cardiovascular Disease, and Orthostatic Hypotension in Older AdultsK23HL135273 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JURASCHEK, STEPHEN P · 2017 to 2021
$1.1M
NHLBI NIH HHS K23 HL135273
6 · The paper itself

Abstract

backgroundHypertension (HTN) in pregnancy is a leading cause of maternal mortality in the United States. Contraception is widely used, and estrogen-based combined hormonal forms are known to increase blood pressure (BP). With nearly half of pregnancies unplanned and many antihypertensive medications teratogenic, appropriate contraception is critical in child-bearing age women with HTN.

methodsUsing the National Health and Nutrition Examination Surveys (NHANES) from 2001 to 2018, we evaluated contraception and antihypertensive medication use in women of child-bearing age (20-50 years). Women who had undergone sterilization or menopause were excluded. HTN was defined based on a self-reported provider diagnosis and BP ≥130/80 mm Hg or antihypertensive medication use. Contraception included non-barrier methods (pills/patch/ring, injections, long-acting reversible contraceptives) or consistent condom use. Multivariable logistic regression was used to model the odds of contraception use. Temporal trends in contraception use were reported.

resultsOf the 8726 women, 12.4% had HTN with mean age (standard error) 36.0 (0.3) years. In women with HTN, 9.2% used non-barrier contraception and 10.4% used condoms only. Over half (52.7%) of women with HTN on antihypertensive medications were taking medications contraindicated in pregnancy, with no difference seen by contraceptive status. In logistic regression models, contraceptive use was lower in the older-aged women. In women with HTN on non-barrier contraception, combined hormonal contraceptive use declined, from 100% (2001-2006) to 81.4% (2013-2018, P < 0.001).

conclusionsMany women with self-reported HTN are not using adequate contraception. Of the small proportion on non-barrier contraceptives, the majority are using estrogen-based, BP-raising methods.

Indexed as

Contraceptive AgentsHypertensionAdultContraceptionFemaleHumansMiddle AgedNutrition SurveysPregnancySterilization, ReproductiveUnited StatesYoung AdultContraceptive Agents

Identifiers

PMID35081582
PMCPMC10122757
OpenAlexW4210300732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.